BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18442196)

  • 1. Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis.
    Hass HG; Nehls O; Jobst J; Frilling A; Vogel U; Kaiser S
    World J Gastroenterol; 2008 Apr; 14(16):2501-10. PubMed ID: 18442196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays.
    Hass HG; Vogel U; Scheurlen M; Jobst J
    Gut Liver; 2018 May; 12(3):306-315. PubMed ID: 29271183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver.
    Hass HG; Vogel U; Scheurlen M; Jobst J
    Oncology; 2018; 95(4):211-219. PubMed ID: 29920486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
    Dumur CI; Campbell DJ; DeWitt JL; Oyesanya RA; Sirica AE
    Exp Mol Pathol; 2010 Dec; 89(3):227-35. PubMed ID: 20816680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of intrahepatic cholangiocarcinoma.
    Subrungruanga I; Thawornkunob C; Chawalitchewinkoon-Petmitrc P; Pairojkul C; Wongkham S; Petmitrb S
    Asian Pac J Cancer Prev; 2013; 14(1):557-63. PubMed ID: 23534794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags.
    Wang AG; Yoon SY; Oh JH; Jeon YJ; Kim M; Kim JM; Byun SS; Yang JO; Kim JH; Kim DG; Yeom YI; Yoo HS; Kim YS; Kim NS
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1022-32. PubMed ID: 16712791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells.
    Obama K; Satoh S; Hamamoto R; Sakai Y; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2008 Mar; 14(5):1333-9. PubMed ID: 18316552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis.
    Miyata T; Yamashita YI; Yoshizumi T; Shiraishi M; Ohta M; Eguchi S; Aishima S; Fujioka H; Baba H
    Cancer Sci; 2019 Oct; 110(10):3197-3203. PubMed ID: 31361379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
    J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of bcl-2 and bax expression and bcl-2/JH fusion gene in intrahepatic cholangiocarcinoma.
    Guo LL; Xiao S; Guo Y
    World J Gastroenterol; 2004 Nov; 10(22):3251-4. PubMed ID: 15484294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
    Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y
    Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.
    Tonouchi A; Ohtsuka M; Ito H; Kimura F; Shimizu H; Kato M; Nimura Y; Iwase K; Hiwasa T; Seki N; Takiguchi M; Miyazaki M
    Am J Gastroenterol; 2006 Jul; 101(7):1601-10. PubMed ID: 16863567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
    Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
    J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma.
    Matsumura N; Yamamoto M; Aruga A; Takasaki K; Nakano M
    Cancer; 2002 Mar; 94(6):1770-6. PubMed ID: 11920540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs.
    Kawahigashi Y; Mishima T; Mizuguchi Y; Arima Y; Yokomuro S; Kanda T; Ishibashi O; Yoshida H; Tajiri T; Takizawa T
    J Nippon Med Sch; 2009 Aug; 76(4):188-97. PubMed ID: 19755794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
    Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
    Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.
    Dachrut S; Banthaisong S; Sripa M; Paeyao A; Ho C; Lee SA; Kosinski C; Patil MA; Zhang J; Chen X; Sripa B; Pairojkul C
    Asian Pac J Cancer Prev; 2009; 10(4):575-82. PubMed ID: 19827872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma.
    Obama K; Ura K; Satoh S; Nakamura Y; Furukawa Y
    Oncol Rep; 2005 Sep; 14(3):701-6. PubMed ID: 16077978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.